111 related articles for article (PubMed ID: 29735425)
21. Design and synthesis of novel methoxypyridine-derived gamma-secretase modulators.
Rynearson KD; Buckle RN; Herr RJ; Mayhew NJ; Chen X; Paquette WD; Sakwa SA; Yang J; Barnes KD; Nguyen P; Mobley WC; Johnson G; Lin JH; Tanzi RE; Wagner SL
Bioorg Med Chem; 2020 Nov; 28(22):115734. PubMed ID: 33007551
[TBL] [Abstract][Full Text] [Related]
22. Discovery of the Oxadiazine FRM-024: A Potent CNS-Penetrant Gamma Secretase Modulator.
Bursavich MG; Harrison BA; Acharya R; Costa DE; Freeman EA; Hrdlicka LA; Jin H; Kapadnis S; Moffit JS; Murphy D; Nolan SJ; Patzke H; Tang C; Van Voorhies HE; Wen M; Koenig G; Blain JF; Burnett DA
J Med Chem; 2021 Oct; 64(19):14426-14447. PubMed ID: 34550687
[TBL] [Abstract][Full Text] [Related]
23. γ-Secretase modulator in Alzheimer's disease: shifting the end.
Xia W; Wong ST; Hanlon E; Morin P
J Alzheimers Dis; 2012; 31(4):685-96. PubMed ID: 22710916
[TBL] [Abstract][Full Text] [Related]
24. Design and optimization of tricyclic gamma-secretase modulators.
Shi J; Zuev D; Xu L; Lentz KA; Grace JE; Toyn JH; Olson RE; Macor JE; Thompson LA
Bioorg Med Chem Lett; 2016 Mar; 26(5):1498-502. PubMed ID: 26848108
[TBL] [Abstract][Full Text] [Related]
25. Anilinotriazoles as potent gamma secretase modulators.
Velter AI; Bischoff FP; Berthelot D; De Cleyn M; Oehlrich D; Jaroskova L; Macdonald G; Minne G; Pieters S; Rombouts F; Van Brandt S; Van Roosbroeck Y; Surkyn M; Trabanco AA; Tresadern G; Wu T; Borghys H; Mercken M; Masungi C; Gijsen H
Bioorg Med Chem Lett; 2014 Dec; 24(24):5805-5813. PubMed ID: 25454273
[TBL] [Abstract][Full Text] [Related]
26. Pyridazine-derived γ-secretase modulators.
Wan Z; Hall A; Jin Y; Xiang JN; Yang E; Eatherton A; Smith B; Yang G; Yu H; Wang J; Ye L; Lau LF; Yang T; Mitchell W; Cai W; Zhang X; Sang Y; Wang Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
Bioorg Med Chem Lett; 2011 Jul; 21(13):4016-9. PubMed ID: 21636276
[TBL] [Abstract][Full Text] [Related]
27. Discovery of N-ethylpyridine-2-carboxamide derivatives as a novel scaffold for orally active γ-secretase modulators.
Sekioka R; Honda S; Honjo E; Suzuki T; Akashiba H; Mitani Y; Yamasaki S
Bioorg Med Chem; 2020 Jan; 28(1):115132. PubMed ID: 31767402
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators.
Pettersson M; Johnson DS; Subramanyam C; Bales KR; am Ende CW; Fish BA; Green ME; Kauffman GW; Lira R; Mullins PB; Navaratnam T; Sakya SM; Stiff CM; Tran TP; Vetelino BC; Xie L; Zhang L; Pustilnik LR; Wood KM; O'Donnell CJ
Bioorg Med Chem Lett; 2012 Apr; 22(8):2906-11. PubMed ID: 22429469
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent γ-secretase inhibitors.
Aubele DL; Truong AP; Dressen DB; Probst GD; Bowers S; Mattson MN; Semko CM; Sun M; Garofalo AW; Konradi AW; Sham HL; Zmolek W; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Bova MP; Hemphill SS; Basi G
Bioorg Med Chem Lett; 2011 Oct; 21(19):5791-4. PubMed ID: 21885276
[TBL] [Abstract][Full Text] [Related]
30. Generation of Leads for γ-Secretase Modulation.
Mandal M; Buevich A; Caldwell JP; Hyde L; Huang X; Liu X; McKittrick B; Mazzola RD; Pissarnitski D; Palani A; Zhang L; Parker E; Xiao L; Rindgen D; Zhu Z
J Med Chem; 2020 Aug; 63(15):8216-8230. PubMed ID: 32786237
[TBL] [Abstract][Full Text] [Related]
31. Orally bioavailable and brain-penetrant pyridazine and pyridine-derived γ-secretase modulators reduced amyloidogenic Aβ peptides in vivo.
Huang Y; Li T; Eatherton A; Mitchell WL; Rong N; Ye L; Yang XJ; Jin S; Ding Y; Zhang J; Li Y; Wu Y; Jin Y; Sang Y; Cheng Z; Browne ER; Harrison DC; Hussain I; Wan Z; Hall A; Lau LF; Matsuoka Y
Neuropharmacology; 2013 Jul; 70():278-86. PubMed ID: 23485401
[TBL] [Abstract][Full Text] [Related]
32. Design and synthesis of bicyclic heterocycles as potent γ-secretase modulators.
Oehlrich D; Rombouts FJ; Berthelot D; Bischoff FP; De Cleyn MA; Jaroskova L; Macdonald G; Mercken M; Surkyn M; Trabanco AA; Tresadern G; Van Brandt S; Velter AI; Wu T; Gijsen HJ
Bioorg Med Chem Lett; 2013 Sep; 23(17):4794-800. PubMed ID: 23890837
[TBL] [Abstract][Full Text] [Related]
33. Quinazolinones as γ-secretase modulators.
Fischer C; Shah S; Hughes BL; Nikov GN; Crispino JL; Middleton RE; Szewczak AA; Munoz B; Shearman MS
Bioorg Med Chem Lett; 2011 Jan; 21(2):773-6. PubMed ID: 21190851
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators (Part 2).
Takai T; Koike T; Nakamura M; Kajita Y; Yamashita T; Taya N; Tsukamoto T; Watanabe T; Murakami K; Igari T; Kamata M
Bioorg Med Chem; 2016 Jul; 24(14):3192-206. PubMed ID: 27255179
[TBL] [Abstract][Full Text] [Related]
35. Presenilin-1 but not amyloid precursor protein mutations present in mouse models of Alzheimer's disease attenuate the response of cultured cells to γ-secretase modulators regardless of their potency and structure.
Hahn S; Brüning T; Ness J; Czirr E; Baches S; Gijsen H; Korth C; Pietrzik CU; Bulic B; Weggen S
J Neurochem; 2011 Feb; 116(3):385-95. PubMed ID: 21091478
[TBL] [Abstract][Full Text] [Related]
36. The discovery of fused oxadiazepines as gamma secretase modulators for treatment of Alzheimer's disease.
Li H; Qin J; Dhondi P; Zhou W; Vicarel M; Bara T; Cole D; Josien H; Pissarnitski D; Zhu Z; Palani A; Aslanian R; Clader J; Czarniecki M; Greenlee W; Cohen-Williams M; Hyde L; Song L; Zhang L; Chu I; Huang X
Bioorg Med Chem Lett; 2013 Jan; 23(2):466-71. PubMed ID: 23253441
[TBL] [Abstract][Full Text] [Related]
37. CTF1-51, a truncated carboxyl-terminal fragment of amyloid precursor protein, suppresses the effects of Aβ42-lowering γ-secretase modulators.
Watahiki H; Yagishita S; Futai E; Ishiura S
Neurosci Lett; 2012 Sep; 526(2):96-9. PubMed ID: 22940081
[TBL] [Abstract][Full Text] [Related]
38. Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeys.
Fischer C; Zultanski SL; Zhou H; Methot JL; Shah S; Hayashi I; Hughes BL; Moxham CM; Bays NW; Smotrov N; Hill AD; Pan BS; Wu Z; Moy LY; Tanga F; Kenific C; Cruz JC; Walker D; Bouthillette M; Nikov GN; Deshmukh SV; Jeliazkova-Mecheva VV; Diaz D; Michener MS; Cook JJ; Munoz B; Shearman MS
Bioorg Med Chem Lett; 2015 Sep; 25(17):3488-94. PubMed ID: 26212776
[TBL] [Abstract][Full Text] [Related]
39. Discovery of a novel [3.2.1] benzo fused bicyclic sulfonamide-pyrazoles as potent, selective and efficacious γ-secretase inhibitors.
Ye XM; Konradi AW; Sun M; Yuan S; Aubele DL; Dappen M; Dressen D; Garofalo AW; Jagodzinski JJ; Latimer L; Probst GD; Sham HL; Wone D; Xu YZ; Ness D; Brigham E; Kwong GT; Willtis C; Tonn G; Goldbach E; Quinn KP; Zhang HH; Sauer JM; Bova M; Basi GS
Bioorg Med Chem Lett; 2013 Feb; 23(4):996-1000. PubMed ID: 23312944
[TBL] [Abstract][Full Text] [Related]
40. APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment.
Sjödin S; Andersson KK; Mercken M; Zetterberg H; Borghys H; Blennow K; Portelius E
Alzheimers Res Ther; 2015 Dec; 7(1):77. PubMed ID: 26689589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
